San Antonio, Texas USA (UroToday.com) Matthew Nielson, University of North Carolina, discussed hematuria workup and guideline recommendations. In Europe, imaging may include ultrasound with increasing concerns regarding radiation exposure of computerized tomography urograms (CTU).
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
In a recent study out of Kaiser Health System, overall cancer diagnosis among microhematuria patients was 2.9%. AUA pooled data analysis was similar. There has been discussion regarding risk stratifying microhematuria workup with increasing use of cystoscopy and CTU based on increasing number of risk factors. Cost-effectiveness research has further supported revision of our current guidelines and supports risk stratification to microhematuria workup. Given lack of upper tract findings on microhematuria workup with increasing costs associated with CTU in the current AUA guideline recommendations, there is a need to limit overuse of this imaging modality. Furthermore, radiation exposure is not to be underestimated with inherent risks of secondary malignancy which should not be ignored.
Presented By: Matthew Nielson, University of North Carolina
Written By: Stephen B. Williams, MD and Ashish M. Kamat
17th Annual Meeting of the Society of Urologic Oncology - November 30 -December 2, 2016 – San Antonio, Texas USA